GB201907016D0 - Screening method to determine suitability for participation in a clinical trial - Google Patents
Screening method to determine suitability for participation in a clinical trialInfo
- Publication number
- GB201907016D0 GB201907016D0 GBGB1907016.8A GB201907016A GB201907016D0 GB 201907016 D0 GB201907016 D0 GB 201907016D0 GB 201907016 A GB201907016 A GB 201907016A GB 201907016 D0 GB201907016 D0 GB 201907016D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- participation
- clinical trial
- screening method
- determine suitability
- suitability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9486—Analgesics, e.g. opiates, aspirine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M19/00—Local anaesthesia; Hypothermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Emergency Medicine (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1907016.8A GB201907016D0 (en) | 2019-05-17 | 2019-05-17 | Screening method to determine suitability for participation in a clinical trial |
| PCT/GB2020/051202 WO2020234573A1 (en) | 2019-05-17 | 2020-05-15 | Screening method to determine suitability for participation in a clinical trial |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1907016.8A GB201907016D0 (en) | 2019-05-17 | 2019-05-17 | Screening method to determine suitability for participation in a clinical trial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201907016D0 true GB201907016D0 (en) | 2019-07-03 |
Family
ID=67385121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1907016.8A Ceased GB201907016D0 (en) | 2019-05-17 | 2019-05-17 | Screening method to determine suitability for participation in a clinical trial |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201907016D0 (en) |
| WO (1) | WO2020234573A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202011055D0 (en) * | 2020-07-17 | 2020-09-02 | Ipsen Bioinnovation Ltd | Treatment of post-operative pain |
| CN112967809B (en) * | 2021-04-06 | 2024-01-23 | 联仁健康医疗大数据科技股份有限公司 | Method, device, equipment and storage medium for determining follow-up user |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL99552A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
| JP2003507073A (en) | 1999-08-25 | 2003-02-25 | アラーガン・セイルズ・インコーポレイテッド | Activable recombinant neurotoxin |
| US6903187B1 (en) | 2000-07-21 | 2005-06-07 | Allergan, Inc. | Leucine-based motif and clostridial neurotoxins |
| DE102004043009A1 (en) | 2004-09-06 | 2006-03-23 | Toxogen Gmbh | Transport protein for introducing chemical compounds into nerve cells |
| DE102005019302A1 (en) | 2005-04-26 | 2006-11-16 | Toxogen Gmbh | Carrier for targeting nerve cells |
| FR2930447B1 (en) * | 2008-04-25 | 2010-07-30 | Sod Conseils Rech Applic | THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR THE TREATMENT OF PAIN IN THE CASE OF DIABETIC NEUROPATHY |
| US10011823B2 (en) | 2009-04-14 | 2018-07-03 | Medical College Of Wisconsin, Inc. | Engineered botulinum neurotoxin |
| US8853360B2 (en) | 2010-06-23 | 2014-10-07 | Wisconsin Alumni Research Foundation | Engineered botulinum neurotoxin C1 with selective substrate specificity |
| JP7158371B2 (en) | 2016-07-08 | 2022-10-21 | ザ チルドレンズ メディカル センター コーポレーション | Novel botulinum neurotoxin and its derivatives |
-
2019
- 2019-05-17 GB GBGB1907016.8A patent/GB201907016D0/en not_active Ceased
-
2020
- 2020-05-15 WO PCT/GB2020/051202 patent/WO2020234573A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020234573A1 (en) | 2020-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4034308T3 (en) | Sorting method | |
| EP2693904A4 (en) | Seamless upper for footwear and method for making the same | |
| PL3941673T3 (en) | Method for automatic process monitoring in continuous generation grinding | |
| EP2780458A4 (en) | Plants having enhanced yield-related traits and a method for making the same | |
| EP2521466A4 (en) | Unibody construction footwear and method for making the same | |
| EP2508871A4 (en) | Inspection apparatus, measurement method for three-dimensional shape, and production method for structure | |
| HUE072388T2 (en) | Method and apparatus for manufacturing a unit cell | |
| ZA202204640B (en) | Method for extracting kelp polyphenols | |
| IL277852A (en) | Method for carrying out a measurement process | |
| PL398407A1 (en) | Machine for cigarette making and method for cigarette making using the cigarette making machine | |
| EP2593555A4 (en) | Plants having enhanced yield-related traits and a method for making the same | |
| GB2600581B (en) | Automated offset well analysis | |
| IL287184A (en) | Methanation method in a bioreactor under continuous cell-retention conditions | |
| IL284893A (en) | A method for in vitro cell functional library screening | |
| ATE528089T1 (en) | APPARATUS FOR WORKING IN A METALLURGICAL VESSEL | |
| GB202203099D0 (en) | Structurally-colored articles and methods for making and using structurally-colored articles | |
| GB201907016D0 (en) | Screening method to determine suitability for participation in a clinical trial | |
| IL277769A (en) | Method for inspecting a weld | |
| GB201917101D0 (en) | Method for digesting nucleic acid in a sample | |
| DE502005000709D1 (en) | Cooking method for cooking or poaching in a pan | |
| TWI365504B (en) | Die defect inspecting system for inspecting the defect of a back surface of a die and method for using the same | |
| PT3934818T (en) | Selection machine for waste products and selection method | |
| IL291531A (en) | A method for development ally- activating a cell | |
| IL192650A0 (en) | A method for defects enhancement | |
| PL2040227T3 (en) | Method for inspecting coins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |